Literature DB >> 25370679

Clinical management for complications related to implantable LVAD use.

Koichi Toda1, Yoshiki Sawa.   

Abstract

More than 250 continuous flow LVADs have been implanted in Japan during the last 3 years, with 1-year survival rates of 90%. These excellent results cannot be achieved without VAD teams who know the detail of surgical techniques and perioperative management. Preoperative optimization of RV function is essential and intraoperative managements are focused on adequate balance between right and left ventricle to prevent right ventricular (RV) failure. For postoperative RV failure early institution of temporary RV mechanical support improves outcomes. Immediate CT scanning is crucial if LVAD patients complain of new neurological symptoms. When CT reveals cerebral hemorrhage, INR should be reduced as soon as possible. The driveline (DL) exit site remains a significant source of LVAD-related infections, and orientation and immobilization of the DL is important. Although vacuum assisted closure is useful to facilitate drainage and healing in pump pocket as well as DL infections, urgent heart transplantation, bridging to recovery, or pump exchange may become the only options to eradicate LVAD-related infections. Patients with continuous flow LVAD are more prone to developing de novo aortic insufficiency. Although majority of them can be managed medically, some require surgical intervention. The cause of pump thrombosis is multifactorial, including lowered INR and pump speed, and implantation techniques. It is important to exchange pumps in a timely manner either through a median sternotomy or subcostal incision in highly suspected patients indicated by elevated LDH and left-sided heart failure.

Entities:  

Mesh:

Year:  2014        PMID: 25370679     DOI: 10.1007/s11748-014-0480-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  35 in total

1.  Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch).

Authors:  Soon J Park; Kenneth K Liao; Romualdo Segurola; K P Madhu; Leslie W Miller
Journal:  J Thorac Cardiovasc Surg       Date:  2004-01       Impact factor: 5.209

2.  Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices.

Authors:  Felix Fleissner; Murat Avsar; Doris Malehsa; Martin Strueber; Axel Haverich; Jan D Schmitto
Journal:  Artif Organs       Date:  2013-01       Impact factor: 3.094

3.  Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.

Authors:  Shuichi Kitada; Tomoko S Kato; Sunu S Thomas; Suzanne D Conwell; Cesare Russo; Marco R Di Tullio; Maryjane Farr; P Christian Schulze; Nir Uriel; Ulrich P Jorde; Hiroo Takayama; Yoshifumi Naka; Shunichi Homma; Donna M Mancini
Journal:  J Heart Lung Transplant       Date:  2013-07-11       Impact factor: 10.247

4.  Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy.

Authors:  Sam Baradarian; Marcia Stahovich; Susan Krause; Robert Adamson; Walter Dembitsky
Journal:  ASAIO J       Date:  2006 May-Jun       Impact factor: 2.872

5.  Recovery from hemorrhagic pulmonary damage by combined use of a left ventricular assist system and right ventricular assist system and extracorporeal membrane oxygenation.

Authors:  Shinya Fukui; Goro Matsumiya; Koichi Toda; Osamu Monta; Norihide Fukushima; Hikaru Matsuda; Yoshiki Sawa
Journal:  J Heart Lung Transplant       Date:  2005-11-18       Impact factor: 10.247

6.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

7.  DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience.

Authors:  Taichi Sakaguchi; Goro Matsumiya; Daisuke Yoshioka; Shigeru Miyagawa; Hiroyuki Nishi; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Takayoshi Ueno; Yoshiki Sawa
Journal:  Circ J       Date:  2013-04-18       Impact factor: 2.993

8.  Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.

Authors:  Satoshi Saito; Kenji Yamazaki; Tomohiro Nishinaka; Yuki Ichihara; Minoru Ono; Syunei Kyo; Takashi Nishimura; Takeshi Nakatani; Koichi Toda; Yoshiki Sawa; Ryuji Tominaga; Tadahisa Tanoue; Yoshikatsu Saiki; Yoshiro Matsui; Takahiro Takemura; Hiroshi Niinami; Goro Matsumiya
Journal:  J Heart Lung Transplant       Date:  2014-03-04       Impact factor: 10.247

9.  Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.

Authors:  B Zane Atkins; Zubair A Hashmi; Asvin M Ganapathi; J Kevin Harrison; G Chad Hughes; Joseph G Rogers; Carmelo A Milano
Journal:  J Thorac Cardiovasc Surg       Date:  2013-07-16       Impact factor: 5.209

10.  LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection.

Authors:  Robert S Poston; Shahid Husain; Damian Sorce; Ellieen Stanford; Shimon Kusne; Margaret Wagener; Bartley P Griffith; Robert L Kormos
Journal:  J Heart Lung Transplant       Date:  2003-08       Impact factor: 10.247

View more
  11 in total

1.  Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.

Authors:  George V Letsou; Jatin Anand; Erinn Ogburn; Rohan M Shah; Anand V Ganapathy; William E Cohn; Gabriel Loor; O H Frazier
Journal:  Tex Heart Inst J       Date:  2019-06-01

2.  Readmissions after continuous flow left ventricular assist device implantation.

Authors:  Mitsutoshi Kimura; Kan Nawata; Osamu Kinoshita; Haruo Yamauchi; Yasuhiro Hoshino; Masaru Hatano; Eisuke Amiya; Koichi Kashiwa; Miyoko Endo; Yukie Kagami; Mariko Nemoto; Minoru Ono
Journal:  J Artif Organs       Date:  2017-07-27       Impact factor: 1.731

3.  Evaluation of micro-emboli in a patient with ventricular assist device support with hemolysis.

Authors:  Osamu Seguchi; Kozue Saito; Kazuki Fukuma; Keiko Shimamoto; Takuma Sato; Seiko Nakajima; Haruki Sunami; Kensuke Kuroda; Takamasa Sato; Takuya Watanabe; Hiroki Hata; Masanobu Yanase; Tomoyuki Fujita; Junjiro Kobayashi; Kazuyuki Nagatsuka; Takeshi Nakatani
Journal:  J Artif Organs       Date:  2015-03-22       Impact factor: 1.731

4.  Correlation between driveline features and driveline infection in left ventricular assist device selection.

Authors:  Teruhiko Imamura; Takahide Murasawa; Hironori Kawasaki; Koichi Kashiwa; Osamu Kinoshita; Kan Nawata; Minoru Ono
Journal:  J Artif Organs       Date:  2016-07-22       Impact factor: 1.731

5.  Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.

Authors:  Yaron D Barac; Charles M Wojnarski; Parichart Junpaparp; Oliver K Jawitz; Han Billard; Mani A Daneshmand; Richa Agrawal; Adam Devore; Chetan B Patel; Jacob N Schroder; Carmelo A Milano
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-16       Impact factor: 5.209

6.  Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.

Authors:  Phillip A Coghill; Suren Kanchi; Zheila J Azartash-Namin; James W Long; Trevor A Snyder
Journal:  ASAIO J       Date:  2019-07       Impact factor: 2.872

7.  Omental and deep inferior epigastric artery perforator flap coverage after heart transplantation to manage wide left ventricular assist device exposure with pocket infection.

Authors:  Yusuke Inatomi; Hideki Kadota; Keizo Kaku; Hiromichi Sonoda; Yoshihisa Tanoue; Akira Shiose
Journal:  J Artif Organs       Date:  2018-10-22       Impact factor: 1.731

8.  Evaluation of right ventricular function using liver stiffness in patients with left ventricular assist device.

Authors:  Noriyuki Kashiyama; Koichi Toda; Teruya Nakamura; Shigeru Miyagawa; Hiroyuki Nishi; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Daisuke Yoshioka; Yoshiki Sawa
Journal:  Eur J Cardiothorac Surg       Date:  2017-04-01       Impact factor: 4.191

Review 9.  Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy.

Authors:  Gabriel A Hernandez; Jonatan D Nunez Breton; Sandra V Chaparro
Journal:  Open J Cardiovasc Surg       Date:  2017-06-22

10.  Left ventricular assist device driveline infections in three contemporary devices.

Authors:  Thomas Schlöglhofer; Peter Michalovics; Julia Riebandt; Philipp Angleitner; Martin Stoiber; Günther Laufer; Heinrich Schima; Dominik Wiedemann; Daniel Zimpfer; Francesco Moscato
Journal:  Artif Organs       Date:  2020-11-28       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.